Leprosy pathogen evades critical vitamin D-dependent immune response

   Jan 30, 12:28 pm

Washington, Jan 30 (ANI): The pathogen behind leprosy has an extraordinary ability to dodge the human immune system by inhibiting the antimicrobial responses vital to our defenses, a new study has revealed.

In one of the first laboratory studies of its kind, researchers discovered that the leprosy pathogen Mycobacterium leprae was able to reduce and evade immune activity that is dependent on vitamin D, a natural hormone that plays an essential role in the body's fight against infections.

The pathogen manipulated micro-RNAs, tiny molecules made of ribonucleic acids that carry information and that help regulate genes to direct cell activity, including immune system defenses.

Micro-RNAs are short RNAs that do not code information for proteins, which carry out all cell activity; rather, they bind to the RNAs that do code for proteins and block them.

The new findings demonstrated how an infectious disease pathogen like M. leprae can use micro-RNAs to impact the immune system's fight response.

"We may find that these tiny micro-RNAs can be exploited by pathogens to weaken our immune response," said the study's first author, Dr. Philip T. Liu, an assistant professor of medicine at the Orthopaedic Hospital Research Center and in the department of dermatology at the David Geffen School of Medicine at UCLA.

"By better understanding how pathogens can escape our immune cells, we can design more effective therapies to boost our immune responses to these difficult to treat infections like leprosy."

Leprosy , one of the world's oldest known diseases, is a chronic infectious disease that affects the skin, the peripheral nerves, the upper respiratory tract and the eyes and can lead to disfigurement of the hands, face and feet.

For the study, researchers compared the micro-RNAs in human skin lesions from two types of leprosy: tuberloid leprosy, a milder infection that is more easily contained, and lepromatous leprosy, which is more serious and causes widespread infection throughout the body.

In the lab, the scientists identified 13 micro-RNAs that differed between the two types of leprosy. The micro-RNAs that were found to be more common in lepromatous leprosy seemed to target the genes important for directing key immune system cells, including macrophages and T cells.

The team found that a particular micro-RNA, hsa-mir-21, inhibited the gene activity of the vitamin D-dependent immune pathway used to help fight infection. When researchers neutralized the activity of hsa-mir-21 in macrophages, the cells were able to kill the bacteria again.

"The leprosy pathogen was able to effectively evade the host's immune response by regulating critical immune system genes," said senior investigator Dr. Robert Modlin, UCLA's Klein Professor of Dermatology and chief of dermatology at the Geffen School of Medicine.

"It's like having the enemy sending a decoy message to your combat troops and telling them to lower their weapons."

To test the significance of this micro-RNA with other infectious diseases, the researchers also introduced hsa-mir-21 to human macrophages that were then infected with tuberculosis in the lab. Researchers found that the micro-RNA similarly blocked the ability of the macrophages to kill the bacteria.

In addition, the team showed that this micro-RNA was found in human immune cells only 18 hours after the onset of leprosy infection. The presence of the micro-RNA so early in the infection suggests it might play a role in actual disease development, the researchers said.

"We may find that a combination of vitamin D supplementation with a genetically targeted therapy could provide an optimal treatment approach to leprosy and possibly other chronic infectious diseases," said Modlin, who also serves as vice chair for cutaneous medicine and dermatological research at UCLA and is a distinguished professor of medicine and of microbiology, immunology and molecular genetics.

The study has been published in the online edition of the journal Nature Medicine. (ANI)

Driverless cars pose 'safety dilemma' Jun 26, 7:08 am
Washington D.C, Jun 26 (ANI): Would you buy a car that might risk your life to save a pedestrian? That's the question researchers are mulling in a recent study about driverless cars.
Full Story
Scientists have new theory on how 'climate' affects 'violence' Jun 25, 8:37 am
Washington D.C, Jun 25 (ANI): Scientists have long struggled to explain why cool heads won't be able to prevail in a hotter world and now, a team of researchers has come up with a model that could help explain why.
Full Story
Dinosaur-era bugs knew how to camouflage Jun 25, 8:00 am
Washington D.C, Jun 25 (ANI): It turns out, insects have been perfecting the art of disguise for a hundred million years.
Full Story
Earth's present magnetic field isn't 'same old, same old' Jun 25, 8:00 am
Washington D.C, Jun 25 (ANI): Turns out, Earth's ancient magnetic field was significantly different than the present day field, originating from several poles rather than the familiar two.
Full Story
Comments